BATTLE Trial: Bare Metal Stent Versus Paclitaxel Eluting Stent in the Setting of Primary Stenting of Intermediate Length Femoropopliteal Lesions

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 186 participants.

Also called NCT02004951

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose health services research
Phase
Not applicable
Enrolled
  • 186 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02004951
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT02004951. Randomized; no masking; primary purpose health services research. Start 2014-03-25 (actual); primary completion 2017-08-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
BATTLE Trial: Bare Metal Stent Versus Paclitaxel Eluting Stent in the Setting of Primary Stenting of Intermediate Length Femoropopliteal Lesions
Acronym
BATTLE
Condition
Peripheral Arterial Disease
Condition
Femoropopliteal Lesions
Intervention (Device)
Misago RX
Intervention (Device)
Zilver PTX
Lead sponsor
Nantes University Hospital (class: other)

Record details

Record id
cardio:ct-nct02004951
Content hash
46d1a3c68966b06f275f1996d5b4aeddac66b6b127fd9005faabfdd576d9fde6